Ycanth (Cantharidin) Revolutionizes Molluscum Contagiosum Treatment with FDA Approval
XTalks
AUGUST 7, 2023
Ycanth (cantharidin) topical solution, developed by Verrica Pharmaceuticals Inc., has received US Food and Drug Administration (FDA) approval for treating molluscum contagiosum in adult and pediatric patients aged two years and older in the US. What is Molluscum Contagiosum?
Let's personalize your content